Swiss drugmaker Novartis AG is nearing an agreement to acquire U.S. biotechnolog...
The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.
Going by a fully diluted share count, the agreement is worth about $10 billion, according to the report.The deal could broaden the Swiss drugmaker’s cabinet of heart medicines and shore up growth threatened by patent expirations. Novartis has been hunting for a $5 billion acquisition in the United States, two banking sources told Reuters earlier this week without identifying a target.
New Jersey-based The Medicines Co’s top drug candidate is cholesterol-lowering drug inclisiran for heart patients. Novartis has historically had a strong cardiovascular drug franchise, but lost ground when Diovan, once a $6 billion-per-year seller, lost patent protection in 2012 and left the company without an immediate, innovative follow-up product.
Novartis has since been building up its portfolio, which now includes Entresto, a $1 billion seller for heart failure, as well as an experimental RNA-targeting molecule from Ionis Pharmaceuticals that it licensed earlier this year for $150 million.Our Standards:
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Novartis reportedly nears deal to buy cholesterol drugmaker Medicines Company for $7 billionNovartis has agreed to pay $85 a share for Medicines Company in a deal that could be reached this weekend, according to The Wall Street Journal.
Leer más »
Chinese antitrust regulator approves Boeing-Embraer dealA Chinese antitrust regulator has approved Boeing Co's deal to buy a contro...
Leer más »
KKR reaches halfway in $3 billion Asia infrastructure fundraising: sourceGlobal private equity group KKR & Co has raised $1.5 billion for its first Asia-...
Leer más »
Bridgewater Associates bets over $1 billion on market drop: WSJBridgewater Associates LP, a hedge fund founded by billionaire Ray Dalio, has be...
Leer más »
John Sherman Buys Kansas City Royals For $1 BillionThe Kansas City Royals have been bought by Kansas City businessman and former Cleveland Indians minority owner John Sherman for $1 billion
Leer más »